Cancer Research Institute
CRI Technology Impact Award: Turning Bold Visions into Breakthroughs in Cancer Immunotherapy

Supports early-stage, pre-development concepts that hold the potential to transform the landscape of cancer immunotherapy.

Deadline: November 15, 2025, letter of intent; if invited, full proposals due March 2, 2026

Funding: $600,000

Purpose:
The CRI Technology Impact Award aims to bridge the gap between conceptual technological innovation and real-world clinical application. By encouraging collaboration between technology developers and clinical cancer immunologists, CRI hopes to accelerate the creation of technologies that can generate proof-of-principle data and unlock novel biological insights.

Eligibility:
Applicants must hold a tenure-track position at a not-for-profit research center or institution. Clinical cancer immunologists and technology developers are encouraged to collaborate. Co-PIs are eligible and encouraged to apply.

Cancer Research Institute
CRI Clinic and Laboratory Integration Program: Accelerating the Translation of Immunological Discoveries into Cancer Therapies

Supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology.

Deadline: December 1, 2025, letter of intent; if invited, full proposal due March 2, 2025

Funding: $300,000 over two years

Purpose: The CRI Clinic and Laboratory Integration Program (CLIP) supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology.

Eligibility: Candidates for a CRI CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the letter of intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation.

---

Cancer Research Institute
CRI Clinical Innovator: Advancing Breakthrough Immunotherapy Trials to Transform Patient Care

Supports pioneering immunotherapy clinical trials designed and led by academic researchers.

Deadline: December 1, 2025, protocol concept; if invited, full proposal due April 4, 2026

Funding: $1M per trial

Career Stage: Early Career

Purpose:
The CRI Clinical Innovator supports pioneering immunotherapy clinical trials designed and led by academic researchers. These investigator-initiated studies are vital to improving patient outcomes, addressing areas of high unmet need, and generating critical mechanistic insights that can guide the future of cancer treatment.

Eligibility:
Candidates must be the principal investigator (PI) of the proposed study. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools or research centers in the United States or abroad.

---

Alzheimer’s Association

Deadline: December 1, 2025, 5 p.m. ET

Funding:
The foundation anticipates funding up to three Zenith Fellows Awards. Each award is limited to $450,000 total funding (direct and indirect costs) over a period of up to three years. Requests in any given year may not exceed $250,000 (direct and indirect costs).

Purpose:
The objective of the 2026 Zenith Fellows Awards competition is to provide funding support for investigators who have:

• Contributed significantly to today’s scientific progress including AD/ADRD.
• Contributed significantly to neuroscience breakthroughs that have informed our broader understanding of AD/ADRD.
• Are likely to make substantial contributions in the future with their proposed work.

The Zenith Fellows program is unique in focusing specifically on biological studies and clinical investigations (excluding clinical trials). Innovative and novel ideas to address research challenges are the core of the Alzheimer’s Association's scientific program. The Alzheimer’s Association is committed to minimizing health disparities and increasing representation of all populations within research and clinical trials.

Eligibility:

• Only established independent investigators are eligible as evidenced by:
• Academic level: Applicant must be an associate professor or above at the time of application.
• Major, peer-reviewed, external multi-year grant support on which the applicant is the principal investigator (PI).
• Independent laboratory operation.
• Quality and independence of publication record.
• Only applicants who have already contributed significantly to the field of AD/ADRD research and/or have the clear likelihood of making significant contributions will be seriously considered.

---

Micheal J. Fox Foundation
The Edmond J. Safra Fellowship in Movement Disorders

Deadline: December 4, 2025

Funding: $180,000

Purpose:
The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson's disease and other movement disorders — by training clinician-researchers who can provide expert care and lead scientific advances. As the demand for movement disorder specialists increases, not enough neurologists are receiving vital training in Parkinson’s and related conditions. To address this need, the Michael J. Fox Foundation (MJFF), in collaboration with longtime partner the Edmond J. Safra Foundation, launched the Edmond J. Safra Fellowship in Movement Disorders. The program annually funds academic centers to each train a new movement disorder clinician-researcher over a two-year period and is growing an international, collaborative network of next-generation leaders in Parkinson’s research and care.

Eligibility:
The program grants funding directly to academic centers, which then must identify and train a new movement disorder clinician-researcher over a two-year period.

---

CART (Coins for Alzheimer’s Research Trust)

Deadline: December 5, 2025, letter of intent; if selected, full proposal due February 13, 2026

Funding:
Applications may encompass a project period of up to two years with a combined budget for direct costs up to $500,000. No indirect costs are allowed.

Purpose:
The goal of CART is to encourage exploratory and developmental Alzheimer’s disease (AD) research projects within the United States by providing support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data but have the potential to substantially advance biomedical research. This proposal should be distinct from those projects designed to increase knowledge in a well-established area unless it is intended to extend previous discoveries toward new directions or applications. Our review team of distinguished neurodegenerative disease researchers is looking for “the best science that is most promising for leading to better diagnoses and/or treatment.”

Submit email questions and letters of intent to Sarah K. Goforth, PhD, acting vice-president for research grants, at skgoforth@gmail.com.

Eligibility:

• Full-time faculty (or the equivalent status).
• This is for NEW projects only.

---

Michael J. Fox Foundation
Parkinson’s Disease Therapeutics Pipeline Program

Deadline:

• Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission.
• If invited, full proposal is to be submitted through one of the five review cycles:
  • December 11, 2025
  • February 22, 2026
  • April 23, 2026
  • June 25, 2026
  • October 2026 (date TBD)

Funding: $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage pre-clinical and/or clinical programs.

Purpose:
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop or delay disease progression or to reduce the burden of daily symptoms.

MJFF prioritizes pre-clinical and clinical programs that may slow, stop or prevent disease
progression, efforts that address moderate-to-advanced motor or non-motor symptoms of
Parkinson’s not well-managed by current treatments such as advanced gait disturbances (e.g., balance issues linked to falls, freezing) and cognitive changes. Activities within scope of this program include:

• Pre-Clinical: Identifying, validating and/or developing novel pharmacological and nonpharmacological interventions through pre-clinical development from early screening to pre-clinical characterization and testing.
• Clinical: Progressing promising interventions with strong preclinical packages into/through initial clinical assessment exploring pharmacokinetics and pharmacodynamics, safety/tolerability, or early proof of biology and/or clinical efficacy. For novel targets, MJFF is particularly interested in de-risking programs by supporting early proof of concept in patients to gain insight into the therapeutic potential, including exploration of biomarker-based or clinical endpoint-based efficacy

Eligibility:
The foundation is only accepting applications from industry groups or academic teams working in collaboration with a dedicated industry partner capable of further commercial development of a promising intervention. Further, our goal is to provide funding to de-risk therapeutic programs and catalyze investment by other funders. We do not anticipate serving as the sole funder for any program and encourage applicants to seek additional financial partnerships.

---

Bryon Riesch Paralysis Foundation

Deadline: December 12, 2025

Funding: The amount of grant money distributed is pre-determined by the Bryon Riesch Paralysis Foundation (BRPF) Board of Directors. Typical grants range from $45,000 to $100,000.

Career Stage: All career stages including postdocs

Purpose:
The goal of the Bryon Riesch Paralysis Foundation is to provide grants to fund research in the hopes of finding a cure for paralysis.  The intent of these grants is to promote new and exciting research in the field of paralysis. Overhead costs not covered. The following areas of research are of primary interest to the Bryon Riesch Paralysis Foundation:

• Factors relating to re-myelination, axonal preservation or growth, and cell differentiation that may lead to acute or chronic recovery in spinal cord injured individuals.
• Drug therapies or other interventions that would limit secondary damage after a spinal cord injury.
• Activities that investigate underlying problems associated with neurological disorders such as spasticity, chronic pain, bladder/bowel function or sexual function.

---

Elsa U. Pardee Foundation

Deadline: December 15, 2025

Funding:
By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested. Projects are supported for one year.

Career Stage/Eligibility:
Investigators who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.

Purpose:
The Elsa U. Pardee Foundation funds research to investigators in United States nonprofit institutions proposing research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period, which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

---

American Federation for Aging Research

Deadline: December 15, 2025, letter of intent

Funding: Up to $160,000 for a one- to two-year award

Career Stage: Early career

Purpose: To conduct research that will serve as the basis for longer-term research efforts on the biology of aging. These investigators study a broad range of biomedical and clinical topics related to aging.

Eligibility:

• An independent investigator with independent research space as described in a form completed by the dean or department chair.
• No more than 10 years beyond the start of postdoctoral research training as of July 1, 2026. Exceptions to the ten-year rule may be considered for certain life events (e.g., familial, personal commitments or other exceptional circumstances) and may be requested by emailing an NIH-style biosketch to AFAR at grants@afar.org at least one week prior to the deadline date. COVID-related exception requests are not considered. For awards funded by the GFMR, preference will be given to investigators who are in the first three years of a faculty appointment.

---

Harrington Discovery Institute

Deadline: December 31, 2025

Funding: $100,000

Purpose:
The Brain Health Medicine Scholars selection committee seeks:

• Discoveries demonstrating rigorous science, creativity, innovation and potential for clinical impact
• Any therapeutic modality
• Novel, validated targets 

The Brain Health Medicines Scholar Award provides funding and drug development support to researchers whose work aims to treat, prevent or cure Alzheimer's disease and related dementias. The award includes:

• One-year grant
• $100,000 with appropriate justification
• Potential to renew for a second year based on milestones achieved
• Dedicated project manager for the duration of the award
• Drug development, commercial strategy and business development support from Harrington's Therapeutics Development Center experts
• Opportunity to quality for up to $400,000 in additional funding and drug development support

Eligibility

• MD or PhD (or equivalent).
• Faculty position at an accredited academic medical center, university or research institution in the U.S., Canada or U.K., and conduct the majority of their research at that institution.
• A project must have a single principal investigator (PI) who will be named the scholar and who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.

Cancer Research Institute

CRI IGNITE Award: Inspiring Growth and Nurturing Independence Through Excellence

Deadline: January 9, 2026, 11:59 p.m. ET

Funding:

• Phase 1: Foundation Phase – Provides up to two years of mentored postdoctoral funding at $150,000 per year

Career Stage: Postdoctoral

Purpose:
The CRI IGNITE Award supports the transition of outstanding postdoctoral researchers into independent tenure-track investigators. The program offers two sequential phases of funding:

• Phase 1: Foundation Phase – Up to two years of postdoctoral support
• Phase 2: Independence Phase – Up to three years of faculty support

IGNITE provides more than funding — it delivers a structured pathway to independence at a time when such opportunities are shrinking.

Eligibility:

• Must be in a mentored postdoctoral position at time of application
• No more than five years of postdoctoral experience at time of application. Candidates with more than five years postdoctoral experience may be granted an exception. Contact CRI for more information.
• Must commit to a minimum of 12 months of mentored research before transition
• Open to U.S. and international researchers; CRI does not have citizenship requirements
• May conduct research in the U.S. or abroad
• Have not currently or previously held an independent research faculty or tenure-track faculty position, or its equivalent, in academia, industry or elsewhere

---

Whitehall Foundation

Deadline: January 15, 2026,  letter of intent; if invited, full application due June 1, 2026

Funding:
Up to $300,000. The maximum budget is $100,000 per year for the two- and three-year research grants.

Purpose:
Research grants are available to established scientists of all ages working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose.

Eligibility
The applicant must meet all four of the following eligibility requirements in order to participate in the application process:

• Appropriate title – must be an assistant professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
• Independence – to be eligible for consideration an applicant must be considered an independent investigator, as defined by the National Institutes of Health. The Foundation assesses independence based on the faculty appointment, commitment of the institution to the PI as an individual member of the faculty, and the allocation of lab space that is independent and free from the control of other members of the faculty. Each application will be assessed on its own merits, but our emphasis on independence is particularly important when an applicant is continuing at the same institution as their doctoral or postdoctoral advisor. Please note that the Foundation does not consider lab space located within a former mentor’s or advisor's lab to be sufficiently independent even with the title of assistant professor or assistant research professor. These expectations are in line with the Foundation’s goal of supporting young investigators as they launch their careers.
• Status – must hold principal investigator status.
• The Foundation does not fund investigators who have substantial (more than $200,000 per year) extramural funding calculated as total direct funds per year less any PI salary/fringe taken from these grants. If this amount is greater than $200,000 the PI would not be eligible for Whitehall Foundation funding. As of December 1, 2024, the Foundation no longer includes indirect funding in the extramural funding calculation. Startup funds and internal funding should be disclosed but are not included in the extramural funding calculation.

Grants in Aid Program
The Grants-in-Aid program is designed for researchers at the assistant professor level who experience difficulty in competing for research funds because they have not yet become firmly established. Grants-in-Aid can also be made to senior scientists. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity. Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

---

Cancer Research Institute
Lloyd J. Old STAR Program

Deadline: January 15, 2026

Funding: $1.2M; funding is over a five-year period (up to $250,000 per year) to tenure-track assistant professors (minimum three years) and associate professors (maximum three years).

Career Stage: Mid-career

Purpose:
Provides long-term funding to mid-career scientists, giving them the freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy. Grants are not tied to a specific research project, but rather support outstanding researchers based on the quality and promise of their overall work.

Eligibility:

• The applicant must have an MD, PhD or MD/PhD (or equivalent)
• Applicants must belong to one of the following categories as of July 1 (following the deadline):
  • Tenure-track assistant professor with a minimum of three years in this position (for Jan. 15, 2026, deadline, must be appointed on or before July 1, 2023)
  • Tenure-track associate professor with a maximum of three years in this position (for Jan. 15, 2026, deadline, must be appointed on or after July 1, 2023)
  • Adjunct or acting positions are not eligible.
  • Applicants are expected to commit a minimum of 80% of their time to conducting research.

---

The Mathers Foundation– Limited Submission

IMPORTANT: Institutional nomination is required to apply. Each institution may nominate up to three researchers (principal investigators) per cycle. Institutional nominations are required at least two weeks before the current cycle’s due date. The designated administrative contact must email the nominees’ names and project titles to grants@mathersfoundation.org 

Deadlines:
Institutional nominations and portal registration:

• January 30, 2026, 8 p.m. ET
• September 19, 2026, 8 p.m. ET

LOI application:

• February 13, 2026, 8 p.m. ET. If invited, full proposal due April 24, 2026, 8 p.m. ET
• October 3, 2026, 8pm ET. If invited, full proposal due December 12, 2026, 8pm ET

Funding: $600,000-700,000, inclusive of 10% indirect costs, over three years

Purpose:
Research areas supported: immunology, microbiome, structural biology, cellular physiology, cancer biology, genetics, genomics, microbiology and infectious diseases, stem cell biology, neuroscience. The list is not exhaustive and may be subject to change or interpretation by the Board.

Eligibility:

• Institutions that directly support their own investigators
• Principal investigators with their own fully equipped labs
• All levels of professorship
• Collaborative research projects with other U.S.-based organizations

---

Campbell Foundation – Limited Submission

Deadline: January 31, 2026
LOIs are accepted during January, April, July and October of each year. Due to our funding limitations, we are only able to consider LOIs from one research team at any given institution within a one-year time frame.

Funding:
Most grant funding is between $60,000 to $100,000. The Foundation has co-funded and has provided partial funding for more costly research projects.

Purpose:
The Campbell Foundation invites letters of intent for its research grants that support novel research relevant to the HIV community at large within five to seven years from date of completion.
It was Mr. Zahn's wish that his private, independent foundation support nonprofit organizations conducting clinical, laboratory-based research into the prevention and treatment of HIV/AIDS, and related conditions and illnesses.

Eligibility:
Funding is restricted to those organizations providing proof of IRS 501(c)(3) status. Applications are not accepted from individuals or for-profit entities.

Klingenstein Philanthropies
Fellowship Awards in Neuroscience

Deadline: February 1, 2026

Funding: $150,000 per year for three years ($450,000 total)

Career Stage: Early Career

Purpose:
The Klingenstein Fellowship Awards in Neuroscience supports early-career investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. Several areas within neuroscience are of particular interest:

• Cellular and molecular neuroscience. Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior.
• Neural systems. Studies of the integrative function of the nervous system.
• Translational research. Studies to improve our understanding of the causes, prevention, diagnosis and treatment of neurological and psychiatric disorders.

Eligibility:
To qualify for an award, investigators must hold a PhD and/or an MD, and have completed all research training, including postdoctoral training. Candidates must also meet these four qualifications at the time of the application deadline:

• The candidate must have a tenure-track appointment or equivalent. A letter indicating the date of appointment and the commitment of institutional resources to establish the investigator and the prospects for long-term support by the institution must be provided by an institutional official (e.g., an offer letter from the dean or department chair).
• The candidate must be an independent investigator at a university, medical center or research institute with a maximum of four years between the completion of last postdoc and the application deadline.
• Applicants must have a primary tenure-track position at an institution in the United States.
• Applicants must inform the Esther A. & Joseph Klingenstein Fund of other sources of funding. Although there’s no strict prohibition against holding more than one fellowship at one time, the fund may take other funding into account when deciding whether to grant an award.

Cancer Research Institute
CRI Irvington Postdoctoral Fellowship Program: Training the Next Generation of Leaders in Immunology and Cancer Research

Deadlines: March 2, 2026, September 1, 2026

Funding:  $228,000 over three years

Career Stage: Early career

Purpose:
The program emphasizes training through research, supporting hypothesis-driven, mechanistic studies in both fundamental immunology and tumor immunology. The applicant and sponsor are expected to demonstrate:

• How the proposed research will advance understanding of the immune system’s role in cancer.
• How the fellowship will provide the fellow with new skills, approaches and mentorship to expand their expertise.
• A clear trajectory toward independence, with training experiences designed to prepare the fellow for leadership roles in science.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.

---

Cancer Research Institute
CRI Immuno-Informatics Postdoctoral Fellowship: Cultivating the next generation of leaders at the Intersection of immunology and data science.

Deadlines: March 2, 2026, September 1, 2026

Funding: $228,000 over three years

Career Stage: Early career

Purpose:
The CRI Immuno-Informatics Fellowship is designed to support:

• Computational biologists seeking to deepen their understanding of immunology.
• Cancer immunologists aiming to gain expertise in computational biology, data science and/or genomics.
• Researchers from diverse PhD backgrounds pursuing training at the interface of cancer immunology and computational biology.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.

Pew Biomedical Scholars – Limited Submission

Deadlines:
Pending announcement from foundation: Early April 2026
Submission of online survey with name and contact information for nominated candidate: May 14, 2026
Online application website opens: June 11, 2026
Application deadline: September 3, 2026

Funding: $300,000; $75,000 per year for a four-year period.

Purpose: Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Eligibility:

• Hold a doctorate in biomedical sciences, medicine or a related field, including engineering or the physical sciences.
• As of September 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor or instructor are not eligible.)
• Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 11, 2021, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
• Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. This extension will end after this upcoming application cycle. Beginning next year, the eligibility window for the 2027 grant will revert to the three-year period. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2026 online application.
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

W.W. Smith Charitable Trust – Limited Submission 

A maximum of one (1) proposal per parent organization may be submitted in each granting category (i.e., heart disease, cancer or AIDS) regardless of the number of EINs available under the organization.

Focus: Heart disease, cancer and AIDS research

Deadline: July 15, 2026, 11:59 p.m. EDT

Funding: $100,000 to $125,000

Purpose:
The Trust awards grants for basic medical research primarily related to heart disease, cancer and AIDS. The Trust invests in promising researchers having the potential to attract larger-scale awards (e.g., NIH, NSF, AHA) subsequent to Trust support.

Eligibility:
Each organization may submit no more than one grant application for each discipline – heart disease, cancer and AIDS. It is up to each organization to conduct an internal selection process to determine the one principal investigator/research project to represent the institution for each discipline.

Michael J. Fox Foundation

The Alzheimer’s Association and the Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.

Deadline: 15th of the month (or the following Monday, if the 15th falls on a weekend).
If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET. If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET.

Funding: Principal investigators may apply for bridge funding spanning three to 12 months for U.S. and international projects impacted by changes in the NIH.

Career Stage: Early Career

Purpose:
This program specifically aims to 1) ensure support for early career researchers (based on NIH definition), who have not yet had the opportunity to fully establish their labs and position their projects for ongoing funding, and 2) provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, dementia with Lewy bodies, atypical Parkinson's and/or other related disorders that have been impacted by a series of changes at NIH.

---

Cardiovascular Medical Research and Education Fund
Improving the Treatment of Pulmonary Diseases

Deadline: Rolling

Funding:
Preference will be given to proposals that have budgets below $100,000 and timelines less than two years.

Purpose:
The CMREF mission of the fund is to support educational activities that will enhance the knowledge of pulmonary hypertension and research projects that may help uncover the causes and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH) in pursuit of the ultimate goal of its treatment and cure. The CMREF does not have a formal application process to fund clinical research or educational projects but is always interested in potentially providing full or partial support to initiatives that are novel, innovative or address the spectrum of unmet medical needs related to pulmonary vascular diseases.

Interested parties should submit a letter of intent (maximum of two pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods. In addition, the letter should mention the length of time of the project and an estimated overall budget.

How to Apply:
To submit your letter, please use the form on this page. Please be sure to fill out all fields and upload your letter before submitting. You can also email your letter directly to Patt Wolfe (executive director) at patt.wolfe@ipahresearch.org.

After you submit your letter, the CMREF will respond within four weeks to inform you if a full application will be requested.

---

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

• Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
• Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
• Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

---

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

• Graduate students
• Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.

 Back to Top